The Effects of LY2409021 on the Liver

Clinical trial NCT01588366 · COMPLETED

Trial details

NCT number: NCT01588366
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2012-04-01
Primary completion: 2013-09-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.